Minocycline is cytoprotective in human corneal endothelial cells and induces anti-apoptotic B-cell CLL/lymphoma 2 (Bcl-2) and X-linked inhibitor of apoptosis (XIAP)

British Journal of Ophthalmology

Volumn 94, Issue 7, 2010, Pages 940-946

  Kernt, Marcus ^a   Hirneiss, C ^a   Neubauer, A S ^a   Kampik, A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; HYDROGEN PEROXIDE; MESSENGER RNA; MINOCYCLINE; PROTEIN BCL 2; TETRAZOLIUM; TRANSFORMING GROWTH FACTOR BETA; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CORNEA ENDOTHELIUM; DNA FRAGMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; CELLS, CULTURED; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, CORNEAL; GENE EXPRESSION REGULATION; HUMANS; MINOCYCLINE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 77954305930     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.165092     Document Type: Article

References (45)

1. Bourne WM, Kaufman HE. The endothelium of clear corneal transplants. Arch Ophthalmol 1976;94:1730-2.
2. Kaufman HE, Katz JI. Pathology of the corneal endothelium. Invest Ophthalmol Vis Sci 1977;16:265-8.
3. Van Horn DL, Hyndiuk RA. Endothelial wound repair in primate cornea. Exp Eye Res 1975;21:113-24.
4. Yee RW, Matsuda M, Schultz RO, et al. Changes in the normal corneal endothelial cellular pattern as a function of age. Curr Eye Res 1985;4:671-8. (Pubitemid 15071017)
5. Bourne WM. One-year observation of transplanted human corneal endothelium. Ophthalmology 1980;87:673-9.
6. Armitage WJ, Easty DL. Factors influencing the suitability of organ-cultured corneas for transplantation. Invest Ophthalmol Vis Sci 1997;38:16-24. (Pubitemid 27051520)
7. Borderie VM, Scheer S, Touzeau O, et al. Donor organ cultured corneal tissue selection before penetrating keratoplasty. Br J Ophthalmol 1998;82:382-8. (Pubitemid 28177147)
8. Temple MD, Perrone GG, Dawes IW. Complex cellular responses to reactive oxygen species. Trends Cell Biol 2005;15:319-26.
9. Lux-Neuwirth O, Millar TJ. Lipid soluble antioxidants preserve rabbit corneal cell function. Curr Eye Res 1990;9:103-9. (Pubitemid 20114979)
10. George AJ, Larkin DF. Corneal transplantation: the forgotten graft. Am J Transplant 2004;4:678-85.
11. Ochiai Y, Ochiai H. Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn J Ophthalmol 2002;46:249-53.
12. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003;113:685-700.
13. Rocha G, Baines MG, Deschenes J, et al. Nitric oxide and transforming growth factor-beta levels during experimental uveitis in the rabbit. Can J Ophthalmol 1997;32:17-24. (Pubitemid 27117605)
14. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990;6:597-641.
15. Huang SS, Huang JS. TGF-beta control of cell proliferation. J Cell Biochem 2005;96:447-62.
16. Yao K, Tan J, Gu WZ, et al. Reactive oxygen species mediates the apoptosis induced by transforming growth factor beta(2) in human lens epithelial cells. Biochem Biophys Res Commun 2007;354:278-83.
17. Chen KH, Harris DL, Joyce NC. TGF-beta2 in aqueous humor suppresses S-phase entry in cultured corneal endothelial cells. Invest Ophthalmol Vis Sci 1999;40:2513-19.
18. Chen KH, Hsu WM, Chiang CC, et al. Transforming growth factor-beta2 inhibition of corneal endothelial proliferation mediated by prostaglandin. Curr Eye Res 2003;26:363-70.
19. Klein NC, Cunha BA. Tetracyclines. Med Clin North Am 1995;79:789-801.
20. Chen M, Ona VO, Li M, et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 2000;6:797-801.
21. Sanchez Mejia RO, Ona VO, Li M, et al. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001;48:1393-9; discussion 99-401.
22. Wang J, Wei Q, Wang CY, et al. Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 2004;279:19948-54.
23. Bosco A, Inman DM, Steele MR, et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 2008;49:1437-46.
24. Bednarz J, Teifel M, Friedl P, et al. Immortalization of human corneal endothelial cells using electroporation protocol optimized for human corneal endothelial and human retinal pigment epithelial cells. Acta Ophthalmol Scand 2000;78:130-6. (Pubitemid 30201417)
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63. (Pubitemid 14203433)
26. Kernt M, Neubauer AS, Liegl R, et al. Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-alpha, Bax, and Bcl-2 expression. J Cataract Refract Surg 2009;35:354-62.
27. Cho KS, Lee EH, Choi JS, et al. Reactive oxygen species-induced apoptosis and necrosis in bovine corneal endothelial cells. Invest Ophthalmol Vis Sci 1999;40:911-19.
28. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
29. Mergler S, Dannowski H, Bednarz J, et al. Calcium influx induced by activation of receptor tyrosine kinases in SV40-transfected human corneal endothelial cells. Exp Eye Res 2003;77:485-95.
30. Lee SM, Yune TY, Kim SJ, et al. Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures. J Neurochem 2004;91:568-78.
31. Wang AL, Yu AC, Lau LT, et al. Minocycline inhibits LPS-induced retinal microglia activation. Neurochem Int 2005;47:152-8.
32. Zanjani TM, Sabetkasaei M, Mosaffa N, et al. Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain. Eur J Pharmacol 2006;538:66-72.
33. Kraus RL, Pasieczny R, Lariosa-Willingham K, et al. Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem 2005;94:819-27.
34. Esposti MD, Hatzinisiriou I, McLennan H, et al. Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen species-sensitive probes. J Biol Chem 1999;274:29831-7. (Pubitemid 129637911)
35. Godley BF, Jin GF, Guo YS, et al. Bcl-2 overexpression increases survival in human retinal pigment epithelial cells exposed to H(2)O(2). Exp Eye Res 2002;74:663-9.
36. Chen J, Flannery JG, LaVail MM, et al. bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations. Proc Natl Acad Sci U S A 1996;93:7042-7.
37. Ryan JJ, Prochownik E, Gottlieb CA, et al. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci U S A 1994;91:5878-82.
38. Clem RJ. Baculoviruses and apoptosis: the good, the bad, and the ugly. Cell Death Differ 2001;8:137-43.
39. McKinnon SJ, Lehman DM, Tahzib NG, et al. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol Ther 2002;5:780-7.
40. Petrin D, Baker A, Coupland SG, et al. Structural and functional protection of photoreceptors from MNU-induced retinal degeneration by the X-linked inhibitor of apoptosis. Invest Ophthalmol Vis Sci 2003;44:2757-63.
41. Olsen T. The endothelial cell damage in acute glaucoma. On the corneal thickness response to intraocular pressure. Acta Ophthalmol (Copenh) 1980;58:257-66.
42. Sihota R, Lakshmaiah NC, Titiyal JS, et al. Corneal endothelial status in the subtypes of primary angle closure glaucoma. Clin Experiment Ophthalmol 2003;31:492-5.
43. Ryan ME, Greenwald RA, Golub LM. Potential of tetracyclines to modify cartilage breakdown in osteoarthritis. Curr Opin Rheumatol 1996;8:238-47.
44. Goulden V, Glass D, Cunliffe WJ. Safety of long-term high-dose minocycline in the treatment of acne. Br J Dermatol 1996;134:693-5. (Pubitemid 26120737)
45. Hartwig H, Mester U, Krasemann C. [Concentration of minocycline in human aqueous humor after oral administration (author's transl)]. Klin Monatsbl Augenheilkd 1978;173:842-5.